Genomtec S.A., announces that the Extraordinary General Meeting of Shareholders of the company appointed Dr. Trevor Hawkins to the Supervisory Board as of April 22, 2024.
Miron Tokarski, co-founder, shareholder, and CEO of Genomtec, comments: “We are very pleased that Dr. Trevor Hawkins – a seasoned leader in business development, R&D, and commercial operations at global healthcare companies, has agreed to join the Supervisory Board of Genomtec. Together with Mr. Gualtiero Garlasco – a veteran of the MedTech industry with vast experience in business development, who was recently appointed to the Supervisory Board, our company has gained two world-class experts who will provide significant support in achieving the company’s strategic goals and developing our innovative technology in the field of genetic diagnostics in infectious diseases and oncology.”
Dr. Trevor Hawkins brings to the Supervisory Board of Genomtec a wealth of experience, including serving as Director of the Human Genome Project at the U.S. Department of Energy and most recently in leadership roles at GE, Philips, Siemens, and HP. Dr. Hawkins currently sits on a number of Boards in the health and life science industry. Commenting on the appointment, Dr. Hawkins said “I am very excited to join the Supervisory Board of Genomtec, as distributed, point of care diagnostics becomes a key aspect of post-covid healthcare. The unique technological approach taken by Genomtec answers key questions from physicians, patients, and payors.”
